GlassScriptPhysician profile
Michael J Sabatini
NPI 1346433703
$6,469.40
in general payments reported to CMS, 2019-2025
42 companies · $969 in 2025
The $969 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $666 · 2021: $1,389 · 2022: $864 · 2023: $637 · 2024: $1,017 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,622.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,175.54 | 2019-2025 | Watchman Access System, Watchman Flx, Rotablator Rotational Atherectomy System Console Kit |
| Janssen Pharmaceuticals, INC | $990.27 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $557.68 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $509.38 | 2020-2023 | Farxiga |
| Medtronic, INC. | $471.52 | 2021-2024 | Corevalve Evolut R, Mycarelink, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $462.69 | 2019-2025 | Mitraclip, Cardiomems, Navitor |
| E.R. Squibb & Sons, L.L.C. | $352.21 | 2019-2025 | Camzyos, Eliquis |
| Bard Peripheral Vascular, INC. | $183.73 | 2021-2023 | Rotarexs 6 F X 135 Cm, Crosser Iq |
| Amgen INC. | $172.05 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $147.09 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $137.40 | 2019-2021 | |
| Bridgebio Pharma, INC. | $132.09 | 2025 | Attruby |
| United Therapeutics Corporation | $97.00 | 2022 | |
| Medtronic Vascular, INC. | $88.24 | 2019 | |
| Novo Nordisk INC | $85.34 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sabatini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.